CLLS Cellectis S.A.

-

Cellectis S.A. Reported Earnings

Thursday, November 12, 2026 · 12:00 AM ET

Cellectis S.A. (CLLS) reported a loss of $0.61 per share on revenue of $5.44 million for the . . Revenue fell 85.36% compared to the same quarter a year ago.

Cellectis SA is a gene-editing company. The company focused on developing immunotherapies based on gene edited engineered CAR-T cells. Cellectis SA is based in Paris, France.

Earnings Whisper Grade —
Power Rating—
Reported Earnings
($0.61)
Earnings Whisper®
—
Consensus Estimate
—
Earnings Surprise
Earnings Growth-6,200.0 %
Reported Revenue
$5.44M
Revenue Estimate
—
Revenue Surprise
Revenue Growth-85.4 %